Pages that link to "Q37509229"
Jump to navigation
Jump to search
The following pages link to Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle (Q37509229):
Displaying 50 items.
- The role of oxidative stress in Parkinson's disease (Q24307946) (← links)
- Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling (Q24608960) (← links)
- The Role of Autophagy, Mitophagy and Lysosomal Functions in Modulating Bioenergetics and Survival in the Context of Redox and Proteotoxic Damage: Implications for Neurodegenerative Diseases (Q26750137) (← links)
- Relationship between Oxidative Stress, Circadian Rhythms, and AMD (Q26765278) (← links)
- Protein kinase D1 (PKD1) activation mediates a compensatory protective response during early stages of oxidative stress-induced neuronal degeneration (Q28582417) (← links)
- Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain. (Q30367032) (← links)
- Proteomic characterization of an isolated fraction of synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells might offer clues to aggresomes as a cellular defensive response against proteasome inhibition by PSI. (Q30479870) (← links)
- PGC-1α rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function. (Q30583566) (← links)
- Inhibition of glycolysis attenuates 4-hydroxynonenal-dependent autophagy and exacerbates apoptosis in differentiated SH-SY5Y neuroblastoma cells (Q33638710) (← links)
- The neurogenic basic helix-loop-helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass. (Q33870484) (← links)
- Effect of single amino acid substitution on oxidative modifications of the Parkinson's disease-related protein, DJ-1 (Q34079628) (← links)
- Transcranial near-infrared laser therapy applied to promote clinical recovery in acute and chronic neurodegenerative diseases. (Q34092740) (← links)
- Astrocytes and Therapeutics for Parkinson's Disease (Q34168266) (← links)
- Protein kinase D1 (PKD1) phosphorylation promotes dopaminergic neuronal survival during 6-OHDA-induced oxidative stress. (Q35164624) (← links)
- Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria. (Q35544534) (← links)
- Supramolecular non-amyloid intermediates in the early stages of α-synuclein aggregation (Q35810050) (← links)
- Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment (Q35853020) (← links)
- Parkinson's disease and autophagy. (Q36355428) (← links)
- Drug discovery in Parkinson's disease-Update and developments in the use of cellular models (Q36680414) (← links)
- Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress (Q36767908) (← links)
- Upstream Pathways Controlling Mitochondrial Function in Major Psychosis: A Focus on Bipolar Disorder (Q37123412) (← links)
- Inhibition of the Fe(III)-catalyzed dopamine oxidation by ATP and its relevance to oxidative stress in Parkinson's disease (Q37186193) (← links)
- Pathophysiology of neuropathic lysosomal storage disorders (Q37739318) (← links)
- Explaining ADAGIO: a critical review of the biological basis for the clinical effects of rasagiline (Q37939755) (← links)
- Defective autophagy in Parkinson's disease: role of oxidative stress. (Q38035191) (← links)
- Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease (Q38038126) (← links)
- Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications (Q38114007) (← links)
- Defective autophagy in Parkinson's disease: lessons from genetics (Q38225786) (← links)
- Sirtuins and proteolytic systems: implications for pathogenesis of synucleinopathies (Q38462113) (← links)
- Regulation of autophagy, mitochondrial dynamics and cellular bioenergetics by 4-hydroxynonenal in primary neurons (Q38610212) (← links)
- GPR30 Activation Contributes to the Puerarin-Mediated Neuroprotection in MPP+-Induced SH-SY5Y Cell Death (Q38735026) (← links)
- Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson's disease (Q38816615) (← links)
- Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress (Q38951473) (← links)
- Neuroprotective effects of ganoderma lucidum polysaccharides against oxidative stress-induced neuronal apoptosis. (Q41043789) (← links)
- Real-Time Amperometric Recording of Extracellular H₂O₂ in the Brain of Immunocompromised Mice: An In Vitro, Ex Vivo and In Vivo Characterisation Study (Q41205578) (← links)
- Imaging nanometer-sized α-synuclein aggregates by superresolution fluorescence localization microscopy. (Q41613707) (← links)
- Neurodegenerative Shielding by Curcumin and Its Derivatives on Brain Lesions Induced by 6-OHDA Model of Parkinson's Disease in Albino Wistar Rats. (Q41853483) (← links)
- Akt as a victim, villain and potential hero in Parkinson's disease pathophysiology and treatment (Q42148662) (← links)
- Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity (Q43193570) (← links)
- Ethyl pyruvate inhibits peroxynitrite-induced DNA damage and hydroxyl radical generation: implications for neuroprotection (Q43273758) (← links)
- Memory impairment and hippocampus specific protein oxidation induced by ethanol intake and 3, 4-methylenedioxymethamphetamine (MDMA) in mice. (Q43776203) (← links)
- Summaries of plenary, symposia, and oral sessions at the XXII World Congress of Psychiatric Genetics, Copenhagen, Denmark, 12-16 October 2014. (Q45022135) (← links)
- Parkinson's Disease Skin Fibroblasts Display Signature Alterations in Growth, Redox Homeostasis, Mitochondrial Function, and Autophagy (Q47833346) (← links)
- Phenotypic variability of parkin mutations in single kindred (Q48437060) (← links)
- Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease (Q49497621) (← links)
- Protein Glutathionylation in the Pathogenesis of Neurodegenerative Diseases (Q49874478) (← links)
- An energy systems approach to Parkinson's disease (Q51639388) (← links)
- Mitochondrial function in individuals at clinical high risk for psychosis. (Q52316654) (← links)
- 3-(Naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride attenuates MPP＋-induced cytotoxicity by regulating oxidative stress and mitochondrial dysfunction in SH-SY5Y cells (Q60048374) (← links)
- Ion-Catalyzed Reactive Oxygen Species in Sporadic Models of Parkinson’s Disease (Q60111586) (← links)